Emtricitabine/tenofovir alafenamide

Redirect to:

This page is a redirect. The following categories are used to track and monitor this redirect:

From an alternative name: This is a redirect from a title that is another name or identity such as an alter ego, a nickname, or a synonym of the target, or of a name associated with the target.
- This redirect leads to the title in accordance with the naming conventions for common names to aid searches and writing. It is not necessary to replace these redirected links with a piped link.
- If this redirect is an incorrect name for the target, then {{R from incorrect name}} should be used instead.

To a section: This is a redirect from a topic that does not have its own page to a section of a page on the subject. For redirects to embedded anchors on a page, use {{R to anchor}} instead.

With possibilities: This is a redirect from a title that potentially could be expanded into a new article. The topic described by this title may be more detailed than is currently provided on the target page or in a section of that page.
- When the target page becomes too large, or for any reason a new page would be an improvement, this redirect may be replaced with an article, template or other project page that is carved out of the target page. See also {{R to section}} and use together with this rcat when appropriate.
- If the topic of the redirect is not susceptible to expansion, then use other rcats such as {{R to section}} or {{R to list entry}} when appropriate.
- Since a new page may be created, links to this redirect should not be replaced with a direct link to the target page. To make redirects to this page, use {{R avoided double redirect}}.
- {{R printworthy}} should be used together with this template when applied to a redirect in mainspace.
- When used on a template redirect, it will automatically populate Category:Template redirects with possibilities.

When appropriate, protection levels are automatically sensed, described and categorized.